Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

NCT01961115 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Mucosal Melanoma
Recurrent Melanoma
Recurrent Uveal Melanoma
Stage IIIA Skin Melanoma
Stage IIIA Uveal Melanoma
Stage IIIB Skin Melanoma
Stage IIIB Uveal Melanoma
Stage IIIC Skin Melanoma
Stage IIIC Uveal Melanoma
Stage IV Skin Melanoma
Stage IV Uveal Melanoma

Interventions

DRUG: Epacadostat
BIOLOGICAL: MELITAC 12.1 Peptide Vaccine

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]
[object Object]
[object Object]